The intersection between human metapneumovirus and the respiratory microbiome

Area of Science:

• * Virology and Microbiology
• * Immunology
• * Public Health

Background:

• * Human metapneumovirus (HMPV) causes respiratory illnesses, ranging from mild to severe.
• * Recent increases in HMPV cases in China highlight its potential for epidemic spread.
• * There are currently no direct antiviral treatments for HMPV, posing challenges for vulnerable populations.

Purpose of the Study:

• * To explore the role of the lung microbiome in HMPV infection.
• * To investigate potential therapeutic strategies targeting the microbiome for HMPV management.
• * To understand how microbial communities influence HMPV pathogenesis and immune response.

Main Methods:

• * Review of recent HMPV outbreaks and epidemiological data.
• * Analysis of the impact of lung microbiome composition on HMPV infection severity.
• * Exploration of microbiome-modulating agents like probiotics, prebiotics, and postbiotics.

Main Results:

• * The lung microbiome composition influences HMPV infection and disease severity.
• * Pathobionts, such as *H. influenzae*, can exacerbate HMPV infections.
• * Advanced technologies like next-generation sequencing and CRISPR-Cas12a enable rapid HMPV detection.

Conclusions:

• * Modulating the lung microbiome presents a promising avenue for HMPV treatment and prevention.
• * Probiotics, prebiotics, and postbiotics warrant further investigation for HMPV management.
• * Understanding host-microbiome interactions is crucial for combating HMPV and similar respiratory viruses.